Breaking News
Get 50% Off 0
🚀 Netflix soars after Q4 earnings. Catch the best Big Tech plays before they report.
Use free screener
Close

Biosenic SA (BIOS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0049 -0.0001    -2.00%
15:58:25 - Real-time Data. Currency in EUR
Type:  Equity
Market:  Belgium
ISIN:  BE0974280126 
  • Volume: 3,776,130
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0045 - 0.0049
Biosenic 0.0049 -0.0001 -2.00%

Biosenic Company Profile

 
Explore the Biosenic company profile for core details about Biosenic, assess Biosenic company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryPharmaceuticals
SectorHealthcare
Employees

20

Equity Type

ORD

Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation.The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration.

Contact Information

Address Rue Granbonpré 11 - Bâtiment H
Mont-Saint-Guibert, 1435
Belgium
Phone 32 49 309 73 66
Fax -

Top Executives

Name Age Since Title
Carlo Chizzolini - - Member of Scientific Advisory Board
Jean-François Bach - - Member of Scientific Advisory Board
Bernard Malissen - - Member of Scientific Advisory Board
Alain Fischer - - Member of Scientific Advisory Board
Frédéric Houssiau - - Member of Scientific Advisory Board
Jules Hoffmann - - Chairman of Scientific Advisory Board
Jean-Luc Vandebroek 52 2022 Non-Executive Director
Jean Stephenne - 2022 Independent Director
Revital Rattenbach - 2022 Independent Director
Yves Sagot 60 2023 Independent Director
Jean-François Rax - 2022 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIOS Comments

Write your thoughts about Biosenic SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email